Venus Remedies Limited (BOM:526953)

Market Cap	7.01B
Revenue (ttm)	6.48B
Net Income (ttm)	453.20M
Shares Out	13.37M
EPS (ttm)	33.90
PE Ratio	15.48
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	624
Average Volume	2,476
Open	499.80
Previous Close	476.00
Day's Range	499.80 - 499.80
52-Week Range	272.20 - 499.80
Beta	0.60
RSI	68.15
Earnings Date	Aug 4, 2025

About Venus Remedies

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products. Venus Remedies Limi...

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 1,187
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 526953

Financial Performance

In 2024, Venus Remedies's revenue was 6.48 billion, an increase of 7.72% compared to the previous year's 6.01 billion. Earnings were 453.20 million, an increase of 59.07%.